[1] Fitzmaurice C, Allen C, Barber RM, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA oncol.3(4),524-48(2017).
[2] Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. The lancet.378(9801),1461-84(2011).
[3] Baschieri A. Health inequities in the Eastern Mediterranean Region Selected country case studies. (2014).
[4] Ghoncheh M, Soltani S, Salehiniya H. Disparities in incidence and mortality of breast cancer. Iran J Public Health.45(2),270-1(2016).
[5] Jahan S. Human development report 2016: human development for everyone: United Nations Publications; 2016.
[6] Organization WH. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. Breast cancer fact sheet[Citated 2018Aug 1] Available at http://globocan iarc fr/Pages/fact_sheets_cancer aspx. (2015).
[7] Institute TJB. The Joanna Briggs Institute Reviewers’ Manual 2014 The Systematic Review of Prevalence and Incidence Data. The Joanna Briggs Institute Reviewers’; 2014.
[8] Hoy D, Brooks P, Woolf A, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol.65(9),934-9(2012).
[9] Keyfitz N. Sampling variance of standardized mortality rates. Am J Hum Biol.38(3),309-17(1966).
[10] Furukawa TA, Barbui C, Cipriani A, et al. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol.59(1),7-10(2006).
[11] Barzin M, Valizadeh M, Serahati S, et al. Overweight and obesity: Findings from 20 years of the Tehran Lipid and Glucose Study. International journal of endocrinology and metabolism.16(4 Suppl)(2018).
[12] von Bortkiewicz L. Das gesetz der kleinen zahlen: BG Teubner; 1898.
[13] Iranian Annual of National Cancer Registration Report 2003-2004. Tehran: Ministry of Health Center for Disease Control& Prevention Non-Communicable Deputy Cancer Office; 2005.
[14] Iranian Annual of National Cancer Registration Report 2010-2011. Ministry of Health Center for Disease Control& Prevention Non-Communicable Deputy Cancer Office; 2013.
[15] Al-Bahrani B, Al-Busaidi A, Al-Lawati NA, et al. Cancer Incidence in Oman 2013. Ministry of Health Soltanate of Oman.
[16] Al-Madouj AN, Eldali A, Al-Zahrani AS. Ten-Year Cancer Incidence Among Nationals Of The GCC States 1998-2007. GCC; 2011.
[17] Al-Masri A, Kofahi S, Al-Ruhaibeh M, et al. Epidemiology of breast cancer in the North Jordan. RMJ.35(2),168-72(2010).
[18] Asgarian F, Mirzaei M, Asgarian S, et al. Epidemiology of breast cancer and the age distribution of patients over a period of ten years. Iran J Breast Dis.9(1),31-6(2016).
[19] Babaei M, Mousavi S, Malek M, et al. Cancer occurrence in Semnan Province, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev.159-64(2005).
[20] Badar F, Mahmood S, Yusuf MA, et al. Epidemiology of cancers in Lahore, Pakistan, 2010–2012: a cross-sectional study. BMJ open.6(6),e011828(2016).
[21] Basaleem H, Al-Sakkaf K, editors. Trends of breast cancer in Aden Cancer Registry, Yemen (1997-2011). Eur J Cancer; 2016: ELSEVIER SCI LTD THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND.
[22] BEN ABDALLAH M, BEN AYOUB WH. Registre Des Cancers NORD-TUNISIE Données 2004 – 2006. MINISTERE DE LA SANTE PUBLIQUE Institut Salah AZAIEZ Institut National de la Santé Publique & MINISTERE DE L’ENSEIGNEMENT SUPERIEUR DE LA RECHERCHE SCIENTIFIQUE ET DE LA TECHNOLOGIE Unité de Recherche en Epidémiologie des Cancers en Tunisie.
[23] Bener A, Ayub H, Kakil R, et al. Patterns of cancer incidence among the population of Qatar: a worldwide comparative study. Asian Pac J Cancer Prev.9(1),19-24(2008).
[24] Benider A, Harif M, Karkouri M. Registre des cancers de la region du grand Casablanca (2005.2006. 2007). Association Lalla Salma de lutte contre le Cancer. (2012).
[25] Bhurgri Y. Karachi cancer registry data--implications for the national cancer control program of pakistan. Asian Pac J Cancer Prev.5(1),77-82(2004).
[26] Bhurgri Y, Bhurgri H, Ajam A, et al. Cancer patterns in Quetta (1998-1999). J Paki Med Assoc.52(12),560(2002).
[27] Bhurgri Y, Naseeruddin S, Zaidi S, et al. Cancer patterns in Karachi division (1998-1999). J Paki Med Assoc.52(6),244(2002).
[28] Bodalal Z, Azzuz R, Bendardaf R. Cancers in eastern Libya: First results from Benghazi medical center. World journal of gastroenterology: WJG.20(20),6293(2014).
[29] Bouchbika Z, Haddad H, Benchakroun N, et al. Cancer incidence in Morocco: report from Casablanca registry 2005-2007. Pan Afr Med J.16(1)(2014).
[30] Curado M-P, Edwards B, Shin HR, et al. Cancer incidence in five continents, Volume IX: IARC Press, International Agency for Research on Cancer; 2007.
[31] Dey S, Soliman AS, Hablas A, et al. Urban–rural differences in breast cancer incidence in Egypt (1999–2006). Breast J.19(5),417-23(2010).
[32] El Mistiri M, Salati M, Marcheselli L, et al. Cancer incidence, mortality, and survival in Eastern Libya: updated report from the Benghazi Cancer Registry. Ann Epidemiol 25(8),564-8(2015).
[33] El Mistiri M, Verdecchia A, Rashid I, et al. Cancer incidence in eastern Libya: the first report from the Benghazi Cancer Registry, 2003. Int J Cancer.120(2),392-7(2007).
[34] El-Zaemey S, Nagi N, Fritschi L, et al. Breast cancer among Yemeni women using the national oncology centre registry 2004–2010. J Cancer Epidemiol.36(3),249-53(2012).
[35] Etemad K, Goya M, Ramazani Darya Sary R, et al. Iranian Annual of National Cancer Registration Report 2007-2008. Tehran: Ministry of Health Center for Disease Control& Prevention Non-Communicable Deputy Cancer Office; 2010.
[36] Etemad K, Goya M, Ramazani Darya Sary R, et al. Iranian Annual of National Cancer Registration Report 2008-2009. Tehran: Ministry of Health Center for Disease Control& Prevention Non-Communicable Deputy Cancer Office; 2011.
[37] Etemad K, Goya M, Ramazani Darya Sary R, et al. Iranian Annual of National Cancer Registration Report 2009-2010. Tehran: Ministry of Health Center for Disease Control& Prevention Non-Communicable Deputy Cancer Office; 2012.
[38] Faramarzi H, Bagheri P, Farahmandfar M, et al. Cancer occurrence in the south of Iran based upon pathology reports (2001–2009) Cas de cancer dans le Sud de l’Iran selon des rapports de pathologie (2001–2009). Afr J Cancer.5(3),137-43(2013).
[39] Fararouei M, Parisai Z, Farahmand M, et al. Cancer incidence appears to be rising in a small province in Islamic Republic of Iran: a population-based cohort study. East Mediterr Health J.21(5),319(2015).
[40] Fateh M, Emamian MH. Cancer incidence and trend analysis in shahroud, iran, 2000-2010. Iran j cancer prev.6(2),85(2013).
[41] Ferlay J, Bray F, Steliarova-Foucher E, et al. Cancer incidence in five continents, CI5plus. IARC CancerBase. (9)(2014).
[42] Fitzmaurice C, Dicker D, Pain A, et al. The global burden of cancer 2013. JAMA oncol.1(4),505-27(2015).
[43] Forman D, Bray F, Brewster D, et al. Cancer incidence in five continents, vol. X (electronic version) Lyon, IARC. 2014.
[44] Ghiasvand R, Adami H-O, Harirchi I, et al. Higher incidence of premenopausal breast cancer in less developed countries; myth or truth? BMC cancer.14(1),343(2014).
[45] Habib OS, Al-Diab J, Mohsin AA, et al. Experience and outcome of population-based cancer registration in Basrah-Southern Iraq in 2005-2008. Asian Pac J Cancer Prev.11(4),1151-4(2010).
[46] Habib OS, Hameed LA, Ajeel NA, et al. Epidemiology of breast cancer among females in basrah. Asian Pac J Cancer Prev.17,91-5(2016).
[47] Hagh Azali M, Ramazani Darya Sary R, DonLoo M, et al. Iranian Annual of National Cancer Registration Report 2002007-6. Tehran: Ministry of Health Center for Disease Control& Prevention Non-Communicable Deputy Cancer Office; 2008.
[48] Hanif M, Sabeen B, Maqbool A, et al. Breast cancer: Incidence (Thirteen year data analysis) and one year clinicopathological data of patients in a tertiary care cancer hospital. Int J Biol Biotech.12(3),373-9(2015).
[49] Hanif M, Zaidi P, Kamal S, et al. Institution-based cancer incidence in a local population in Pakistan: nine year data analysis. Asian Pac J Cancer Prev.10(2),227-30(2009).
[50] Hashemzadeh S, Maleki RA, Golzari SE. The incidence of breast cancer in northwest iran (2003-2008). J Cardiovasc Thorac Res.4(1),5(2012).
[51] Hussain A, Ahmad SB, Muhammad W, et al. Epidemiology of the breast cancer patients registered at Institute of Radiotherapy and Nuclear Medicine, Peshawar, Pakistan. Eur J Cancer Care.17(5),469-76(2008).
[52] Ibrahim AS, Khaled HM, Mikhail NN, et al. Cancer incidence in Egypt: results of the national population-based cancer registry program. J Cancer Epidemiol.2014(2014).
[53] Ismail SI, Soubani M, Nimri JM, et al. Cancer incidence in Jordan from 1996 to 2009: a comprehensive study. Asian Pac J Cancer Prev.14(6),3527-34(2013).
[54] Khoshnaw N, Mohammed HA, Abdullah DA. Patterns of cancer in Kurdistan-results of eight years cancer registration in Sulaymaniyah Province-Kurdistan-Iraq. Asian Pac J Cancer Prev.16(18),8525-31(2015).
[55] Majid RA, Mohammed HA, Hassan HA, et al. A population-based study of Kurdish breast cancer in northern Iraq: hormone receptor and HER2 status. A comparison with Arabic women and United States SEER data. BMC women's health.12(1),16(2012).
[56] Mashhadi M, Zakeri Z, Abdollahinejad M. Cancer incidence in South East of Iran: results of a population-based cancer registry. Shiraz E Med J.11(3),148-55(2010).
[57] Masoompour SM, Lankarani KB, Honarvar B, et al. Changing epidemiology of common cancers in southern iran, 2007-2010: A cross sectional study. PloS one.11(5),e0155669(2016).
[58] Mehrabani D, Almasi A, Farahmand M, et al. Incidence of breast cancer in Fars province, southern Iran: A hospital-based study. World j plast surg.1(1),16(2012).
[59] Mohagheghi S, MOUSAVI JS, Malekzadeh R, et al. Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998–2001. (2009).
[60] Moosavi S, DonLoo M, Hajsadeghi N, et al. Iranian Annual of National Cancer Registration Report 2005-2006 Ministry of Health Center for Disease Control& Prevention Non-Communicable Deputy Cancer Office; 2007.
[61] Moradpour F, Fatemi Z. Estimation of the projections of the incidence rates, mortality and prevalence due to common cancer site in Isfahan, Iran. Asian Pac J Cancer Prev.14(6),3581-5(2013).
[62] Mousavi SM, Mohaghegghi MA, Mousavi-Jerrahi A, et al. Burden of breast cancer in Iran: a study of the Tehran population based cancer registry. Asian Pac J Cancer Prev.7(4),571(2006).
[63] Mzayek F, Asfar T, Rastam S, et al. Neoplastic diseases in Aleppo, Syria. Eur J Cancer Prev.11(5),503-7(2002).
[64] Nimri O, Al-Sayaideh A. Cancer Incidence in Jordan-2012.
[65] Qureshi MA, Mirza T, Khan S, et al. Cancer patterns in Karachi (all districts), Pakistan: first results (2010–2015) from a Pathology based cancer registry of the largest government-run diagnostic and reference center of Karachi. Cancer epidemiol.44,114-22(2016).
[66] Ramazani Darya Sary R, Moosavi S, DonLoo M, et al. Iranian Annual of National Cancer Registration Report 2004-2005. Tehran: Ministry of Health Center for Disease Control& Prevention Non-Communicable Deputy Cancer Office; 2006.
[67] Sadjadi A, Nouraie M, Ghorbani A, et al. Epidemiology of breast cancer in the Islamic Republic of Iran: first results from a population-based cancer registry. (2009).
[68] Sadjadi A, Zahedi M, Nouraie M, et al. The first population-based cancer survey in Kerman Province of Iran. Iran J Public Health.36(4),26-34(2007).
[69] Saeed IE, Weng HY, Mohamed KH, et al. Cancer incidence in Khartoum, Sudan: first results from the Cancer Registry, 2009–2010. Cancer med.3(4),1075-84(2014).
[70] Sellami A, Sellami Boudawara T. Incidence des cancers dans le Gouvernorat de Sfax: 2000–2002. Institut National de la Santé Publique. (2007).
[71] Shamseddine A, Sibai A-M, Gehchan N, et al. Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998∗. Ann Epidemiol.14(9),663-8(2004).
[72] Somi MH, Farhang S, Mirinezhad SK, et al. Cancer in East Azerbaijan, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev.9(2),327-30(2008).
[73] Taheri NS, Nosrat SB, Aarabi M, et al. Epidemiological pattern of breast cancer in Iranian women: is there an ethnic disparity? Asian Pac J Cancer Prev.13(9),4517-20(2012).
[74] TAZI MA, BENJAAFAR N, ER-RAKI A. Incidence des cancers a Rabat – anne´e2005. Assocition scientifique de l,Institu National d,oncologie (ASINO) & Direction deL,Epidemiologie et de lutte contre les Maladies (DELM); 2009.
[75] Tazi MA, Er-Raki A, Benjaafar N. Cancer incidence in Rabat, Morocco: 2006–2008. Ecancermedicalscience.7(2013).
[76] Yavari P, Hislop TG, Bajdik C, et al. Comparison of cancer incidence in Iran and Iranian immigrants to British Columbia, Canada. Asian Pac J Cancer Prev.7(1),86(2006).
[77] Zanetti R, Tazi MA, Rosso S. New data tells us more about cancer incidence in North Africa. European Journal of Cancer.46(3),462-6(2010).
[78] Organization WH. Towards a strategy for cancer control in the Eastern Mediterranean Region. (2009).
[79] Ghoncheh M, Mohammadian-Hafshejani A, Salehiniya H. Incidence and mortality of breast cancer and their relationship to development in Asia. Asian Pac J Cancer Prev.16(14),6081-7(2015).
[80] Hamadeh RR, Abulfatih NM, Fekri MA, et al. Epidemiology of breast cancer among Bahraini women: data from the Bahrain cancer registry. Sultan Qaboos Univ Med J.14(2),e176(2014).
[81] Al-Hashimi M, Wang XJ. Breast cancer in Iraq, incidence trends from 2000-2009. Asian Pac J Cancer Prev.15(1),281-6(2014).
[82] Jazayeri SB, Saadat S, Ramezani R, et al. Incidence of primary breast cancer in Iran: Ten-year national cancer registry data report. Cancer epidemiol.39(4),519-27(2015).
[83] Missaoui N, Trabelsi A, Parkin DM, et al. Trends in the incidence of cancer in the Sousse region, Tunisia, 1993–2006. Int J Oncol.127(11),2669-77(2010).
[84] Shamseddine A, Saleh A, Charafeddine M, et al. Cancer trends in Lebanon: a review of incidence rates for the period of 2003–2008 and projections until 2018. Popul Health Metr.12(1),4(2014).
[85] Lakkis NA, Adib SM, Osman MH, et al. Breast cancer in Lebanon: incidence and comparison to regional and Western countries. Cancer epidemiol.34(3),221-5(2010).
[86] Roshandel; Gholam Reza, Ghanbari Motlagh; Ali, Partoi Poor; Elham, et al. Annual Report of Iranian National Population-Based Cancer Registry (2014). Tehran: Ministry of Health and Medical Education, Deputy of Health Non-Communicable Diseases Control Department Cancer Office, Secretariat of the National Cancer Registry Program; 2018.
[87] Zahmatkesh B, Keramat A, Alavi N, et al. Breast cancer trend in Iran from 2000 to 2009 and prediction till 2020 using a trend analysis method. Asian Pac J Cancer Prev.17(3),1493-8(2016).
[88] Moraga-Serrano PE. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology. (2018).
[89] DeSantis CE, Bray F, Ferlay J, et al. International variation in female breast cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev (2015).
[90] Corbex M, Harford JB. Perspectives on breast cancer in Arab populations. The Lancet Oncology.14(13),e582(2013).
[91] ZAHRA F, HUMAYOUN F, YOUSAF T, et al. Evaluation of risk factors for carcinoma breast in Pakistani women. Journal of Fatima Jinnah Medical University.7(1)(2013).
[92] Asif HM, Sultana S, Akhtar N, et al. Prevalence, risk factors and disease knowledge of breast cancer in Pakistan. Asian Pac J Cancer Prev.15(11),4411-6(2014).
[93] Rosero‐Bixby L, Oberle MW, Lee NC. Reproductive history and breast cancer in a population of high fertility, Costa Rica, 1984–85. International journal of cancer.40(6),747-54(1987).
[94] Madigan MP, Ziegler RG, Benichou J, et al. Proportion of breast cancer cases in the United States explained by well-established risk factors. JNCI: Journal of the National Cancer Institute.87(22),1681-5(1995).
[95] Almasi Z, Mohammadian-Hafshejani A, Salehiniya H. Incidence, mortality, and epidemiological aspects of cancers in Iran; differences with the world data. J BU ON.21(4),994-1004(2016).
[96] Anders CK, Johnson R, Litton J, et al., editors. Breast cancer before age 40 years. Seminars in oncology; 2009: Elsevier.